本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

10.27
-0.5400-5.00%
盘后10.270.00000.00%16:41 EDT
成交量:8.53万
成交额:88.24万
市值:3.52亿
市盈率:-9.73
高:10.87
开:10.67
低:10.15
收:10.81
52周最高:17.15
52周最低:9.85
股本:3,425.49万
流通股本:2,085.08万
量比:0.37
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-1.0553
每股收益(LYR):-1.0472
净资产收益率:-33.50%
总资产收益率:-22.40%
市净率:1.88
市盈率(LYR):-9.81

数据加载中...

2024/09/05

重要事件披露

Form 8-K - Current report
2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/01

重要事件披露

Form 8-K - Current report
2024/05/24

SEC问询函

Form CORRESP - Correspondence
2024/05/16

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/29

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/18

重要事件披露

Form 8-K - Current report
2024/04/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/08

重要事件披露

Form 8-K - Current report
2024/03/02

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/12/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans